A report indicates that approximately 14 million Medicare recipients could potentially obtain GLP-1 medications for approximately $50 per month. GLP-1 drugs are primarily used to manage type 2 diabetes and weight management. The expanded access could significantly reduce out-of-pocket costs for eligible beneficiaries who currently use or are considering these medications.
Weight & Metabolism · Jun 24, 2026 · 5 hours ago
Medicare recipients may access GLP-1 medications at reduced cost
Read the full story at healthline.com →
This summary was prepared by the HealthyFreePress editorial desk; the underlying reporting belongs to the linked publisher. Nothing here is medical advice — see our Medical Disclaimer and Editorial Policy.